These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 2906585
1. Bivalent ligand type beta-adrenolytics related to practolol. Rampa A, Da Re P, Valenti P, Frigeni V, Sala R, Della Bella D. Drugs Exp Clin Res; 1988; 14(9):581-6. PubMed ID: 2906585 [Abstract] [Full Text] [Related]
2. Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation. Da Re P, Valenti P, Fabbri G, Frigeni V, Reggiani A, Della Bella D. Drugs Exp Clin Res; 1988; 14(11):687-92. PubMed ID: 2907738 [Abstract] [Full Text] [Related]
3. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine. Cecchetti V, Fravolini A, Fringuelli R, Schiaffella F, Mascellani G, Pagella PG, Rugarli PL. Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382 [Abstract] [Full Text] [Related]
4. Pharmacological evaluation of new alkylesters of 4-[(2-hydroxy-3-alkylamino)propoxy]phenylcarbamic acids with beta-adrenolytic properties. Racanská E, Csöllei J, Svec P. Pharmazie; 1990 Nov; 45(11):851-3. PubMed ID: 1983125 [Abstract] [Full Text] [Related]
5. [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum]. Leonhardt U, Nürnberger H, Femmer K. Pharmazie; 1975 Oct; 30(10):656-8. PubMed ID: 690 [No Abstract] [Full Text] [Related]
6. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol. Bodem G, Brammell HL, Weil JV, Chidsey CA. J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332 [Abstract] [Full Text] [Related]
11. Potential probe for isolation of the beta-adrenoceptor, chloropractolol. Erez M, Weinstock M, Cohen S, Shtacher G. Nature; 1975 Jun 19; 255(5510):635-6. PubMed ID: 237237 [No Abstract] [Full Text] [Related]
13. [Comparative effects of several beta-adrenergic inhibitors on pulmonary resistance in guinea pigs]. Giudicelli JF, Boissier JR, Dumas Y, Advenier C. C R Seances Soc Biol Fil; 1973 Jun 19; 167(2):232-7. PubMed ID: 4153959 [No Abstract] [Full Text] [Related]
15. [Cholinergic antagonism by beta-blockers. II. Sequence of interactions and final steady state effects]. Re L, Rossini L. Boll Soc Ital Biol Sper; 1980 May 15; 56(9):899-904. PubMed ID: 6108774 [Abstract] [Full Text] [Related]
16. Nonspecific membrane effects of CH-103: hydrophobicity, surface activity and membrane fluidity studies in comparison with propranolol and practolol. Varga E, Szöllösi J, Antal K, Kovács P, Szabó JZ. Pharmazie; 1999 May 15; 54(5):380-4. PubMed ID: 10368833 [Abstract] [Full Text] [Related]
17. [New beta-sympatholytic agents. Synthesis and pharmacological activity of isomeric benzthiazole and benzoxazole derivates (author's transl)]. Franke A, Frickel FF, Gries J, Lehmann HD, Lenke D, Ohnsorge U. Arzneimittelforschung; 1980 May 15; 30(11):1831-8. PubMed ID: 6109536 [Abstract] [Full Text] [Related]
18. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative. Robak J, Grodzińska L. Pol J Pharmacol Pharm; 1973 May 15; 25(3):253-7. PubMed ID: 4150018 [No Abstract] [Full Text] [Related]